New GLP-1 drugs are booming in popularity—12.5 percent of Americans have tried them. The figure is expected to grow by roughly 350 percent by 2035.

The drugs work on the brain to lead people to eat significantly less.

One curious side effect of the drugs: They’re changing how much food we buy and even the types of food we buy.

That’s according to a fascinating and rigorous new study from researchers at Cornell.

Michael spoke to the scientists to learn the details of how GLP-1s are changing shopping, the food industry, and their users.

In this episode, he’ll dive into all the details of their study and what it means for the future of food.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.twopct.com/subscribe